InsiderClue
← All stocks

EXELIXIS, INC.

EXEL Net selling
CIK 0000939767 #814 in the set updated 18 Sep 2026
Bought (120 mo)
$16.46M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$349.82M
$12.08M on a plan · $240.94M straight out of an exercise
Sold at will
$96.81M
131 of 440 sales
Net
−$333.37M
−$80.35M against sales at will

By person

27 insiders · 499 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MORRISSEY MICHAEL
President and CEO
—
$58.19M (59) scheduled
−$58.19M
3,810,385
1.54%
$204.47M
+520.8%
Haley Patrick J.
EVP, Commercial
—
$35.85M (70)
−$35.85M
357,638
0.1443%
$19.19M
+68.7%
Schwab Gisela
Pres, Prod Dev & Med Aff & CMO
—
$34.69M (36) scheduled
−$34.69M
689,078
0.2781%
$36.98M
+375.7%
Hessekiel Jeffrey
EVP & General Counsel
—
$28.18M (41) scheduled
−$28.18M
693,396
0.2798%
$37.21M
+191.6%
Lamb Peter
EVP, Scientific Strategy & CSO
—
$27.46M (26) scheduled
−$27.46M
410,958
0.1659%
$22.05M
+616.6%
Senner Christopher J.
EVP and CFO
—
$24.02M (17) scheduled
−$24.02M
952,317
0.3843%
$51.10M
+887.5%
SCANGOS GEORGE A
Director
—
$23.44M (42)
−$23.44M
714,717
0.2884%
$38.35M
−45.3%
PAPADOPOULOS STELIOS
Director
—
$16.81M (16)
−$16.81M
1,197,595
0.4833%
$64.26M
−3.3%
Aftab Dana
EVP, Research and Development
—
$16.67M (13)
−$16.67M
594,741
0.2400%
$31.91M
+131.3%
JOHNSON DAVID EDWARD
Director
$16.46M (5)
$2.60M (1)
+$13.85M
1,571,438
0.6342%
$84.32M
+72.5%
POSTE GEORGE
Director
—
$12.00M (15) scheduled
−$12.00M
127,199
0.0513%
$6.83M
+64.0%
WILLSEY LANCE
Director
—
$10.20M (13)
−$10.20M
424,415
0.1713%
$22.77M
−25.3%
MARCHESI VINCENT T
Director
—
$8.70M (12) scheduled
−$8.70M
93,989
0.0379%
$5.04M
−21.7%
Smith Julie
Director
—
$8.07M (6) scheduled
−$8.07M
28,957
0.0117%
$1.55M
—
WYSZOMIERSKI JACK L
Director
—
$7.73M (14) scheduled
−$7.73M
284,384
0.1148%
$15.26M
+317.5%
COHEN CHARLES
Director
—
$7.42M (8)
−$7.42M
261,375
0.1055%
$14.03M
+5.3%
Garber Alan M
Director
—
$7.13M (14) scheduled
−$7.13M
35,703
0.0144%
$1.92M
−39.7%
FELDBAUM CARL B
Director
—
$6.83M (14) scheduled
−$6.83M
18,701
0.0075%
$1.00M
−61.6%
Peterson Amy C.
EVP Prod Dev & Med Aff & CMO
—
$3.31M (1) scheduled
−$3.31M
465,393
0.1878%
$24.97M
—
Freire Maria C
Director
—
$2.92M (4) scheduled
−$2.92M
109,186
0.0441%
$5.86M
—
Beckerle Mary C
Director
—
$2.36M (6) scheduled
−$2.36M
16,079
0.0065%
$862.80K
—
Oliver Bob
Director
—
$2.02M (3) scheduled
−$2.02M
29,487
0.0119%
$1.58M
—
Eckhardt Sue Gail
Director
—
$1.87M (6) scheduled
−$1.87M
16,079
0.0065%
$862.80K
—
Hefti Brenda
SVP and General Counsel
—
$1.15M (2) scheduled
−$1.15M
106,762
0.0431%
$5.73M
+17.8%
Heyman Tomas J.
Director
—
$201.25K (1)
−$201.25K
50,649
0.0204%
$2.72M
—
Goodman Vicki L
EVP, Prod Dev & Med Aff &CMO
—
—
—
307,654
0.1242%
$16.51M
—
Wright Jacqueline
Director
—
—
—
51,756
0.0209%
$2.78M
—

Individual transactions

37
Insider
Date
Role
Action
Shares
Price
Amount
MORRISSEY MICHAEL
13 Feb 2026
President and CEO
Exercised, kept
494,700
$21.31
$10.54M
MORRISSEY MICHAEL
14 May 2025
President and CEO
Exercised, kept
308,365
$18.80
$5.80M
Hessekiel Jeffrey
27 Nov 2024
EVP & General Counsel
Exercised, kept
129,314
$18.80
$2.43M
Haley Patrick J.
2 Oct 2024
EVP, Commercial
Exercised, kept
100,000
$24.41
$2.44M
MORRISSEY MICHAEL
1 Oct 2024
President and CEO
Exercised, kept
480,000
$24.41
$11.72M
MORRISSEY MICHAEL
28 Aug 2023
President and CEO
Exercised, kept
360,000
$15.31
$5.51M
MORRISSEY MICHAEL
24 Jan 2023
President and CEO
Exercised, kept
100,000
$4.20
$420.00K
Senner Christopher J.
11 Aug 2022
EVP and CFO
Exercised, kept
225,000
$6.21
$1.40M
Senner Christopher J.
21 Sep 2021
EVP and CFO
Exercised, kept
90,000
$3.66
$329.40K
Schwab Gisela
26 Jul 2021
Pres, Prod Dev & Med Aff & CMO
Exercised, kept
40,000
$4.20
$168.00K
Schwab Gisela
21 Jul 2021
Pres, Prod Dev & Med Aff & CMO
Exercised, kept
35,000
$4.20
$147.00K
COHEN CHARLES
6 Jul 2021
Director
Exercised, kept
40,000
$6.30
$252.00K
COHEN CHARLES
6 Jul 2021
Director
Exercised, kept
40,000
$3.13
$125.20K
MORRISSEY MICHAEL
12 May 2021
President and CEO
Exercised, kept
50,000
$4.20
$210.00K
POSTE GEORGE
22 Feb 2021
Director
Exercised, kept
40,000
$3.38
$135.20K
Hessekiel Jeffrey
4 Jan 2021
EVP and General Counsel
Exercised, kept
20,000
$1.90
$38.00K
Hessekiel Jeffrey
4 Jan 2021
EVP and General Counsel
Exercised, kept
30,000
$7.27
$218.10K
WILLSEY LANCE
4 Dec 2020
Director
Exercised, kept
106,142
$5.82
$617.75K
Hessekiel Jeffrey
15 Nov 2020
EVP and General Counsel
Exercised, kept
30,000
$7.27
$218.10K
Hessekiel Jeffrey
8 Sep 2020
EVP and General Counsel
Exercised, kept
190,000
$6.21
$1.18M
Hessekiel Jeffrey
8 Sep 2020
EVP and General Counsel
Exercised, kept
59,692
$1.90
$113.41K
COHEN CHARLES
1 Sep 2020
Director
Exercised, kept
115,396
$5.82
$671.60K
POSTE GEORGE
14 Aug 2020
Director
Exercised, kept
29,662
$5.82
$172.63K
MORRISSEY MICHAEL
20 Jul 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
MORRISSEY MICHAEL
10 Jul 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
MORRISSEY MICHAEL
19 Jun 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
MORRISSEY MICHAEL
29 May 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
SCANGOS GEORGE A
15 May 2020
Director
Exercised, kept
21,686
$5.82
$126.21K
SCANGOS GEORGE A
15 May 2020
Director
Exercised, kept
30,000
$4.58
$137.40K
MORRISSEY MICHAEL
15 May 2020
President and CEO
Exercised, kept
100,000
$6.21
$621.00K
PAPADOPOULOS STELIOS
13 May 2020
Director
Exercised, kept
120,791
$5.82
$703.00K
Hessekiel Jeffrey
13 May 2020
EVP and General Counsel
Exercised, kept
25,000
$1.70
$42.50K
MORRISSEY MICHAEL
6 May 2020
President and CEO
Exercised, kept
285,284
$1.70
$484.98K
MORRISSEY MICHAEL
27 Apr 2020
President and CEO
Exercised, kept
285,000
$1.70
$484.50K
MORRISSEY MICHAEL
23 Apr 2020
President and CEO
Exercised, kept
250,000
$5.51
$1.38M
MORRISSEY MICHAEL
21 Apr 2020
President and CEO
Exercised, kept
220,000
$5.51
$1.21M
MORRISSEY MICHAEL
20 Apr 2020
President and CEO
Exercised, kept
240,000
$5.51
$1.32M
Showing 250 of 499 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 712
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 8
Sales on a Rule 10b5-1 plan 26
Sales straight out of an exercise 283
Sales at will 131
Transactions with no price 0
Shares from compensation/vesting 41,691,176
Sales filed before the plan box existed 101
History held since 2 Sep 2016